Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

[New oral anticoagulants for the prevention of thromboembolism in atrial fibrillation: from clinical evidence to appropriate use].

Colonna P.

G Ital Cardiol (Rome). 2012 Nov;13(11 Suppl 1):3S-10S. doi: 10.1714/1179.13061. Review. Italian.

PMID:
23160014
2.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
3.

Can we predict stroke in atrial fibrillation?

Lip GY.

Clin Cardiol. 2012 Jan;35 Suppl 1:21-7. doi: 10.1002/clc.20969. Review.

4.

The need for new oral anticoagulants in clinical practice.

Hylek EM.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):605-9. doi: 10.2459/JCM.0b013e32832e4954. Review.

PMID:
19571764
5.

Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.

Deedwania PC, Huang GW.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):265-75. doi: 10.2165/11592410-000000000-00000. Review.

PMID:
21740079
6.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
7.

Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.

Lang NN, Connelly DT.

J R Coll Physicians Edinb. 2013;43(2):151-8. doi: 10.4997/JRCPE.2013.213. Review.

PMID:
23734359
8.

[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

Selçuk H, Selçuk MT, Maden O.

Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8. Review. Turkish.

9.

Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.

Guo Y, Lip GY, Apostolakis S.

Hosp Pract (1995). 2013 Feb;41(1):71-8. doi: 10.3810/hp.2013.02.1012. Review.

PMID:
23466969
10.

New pharmacologic approaches to prevent thromboembolism in patients with atrial fibrillation.

Hammwöhner M, D'Alessandro A, Wolfram O, Goette A.

Curr Vasc Pharmacol. 2007 Jul;5(3):211-9. Review.

PMID:
17627564
11.

Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?

Escobar C, Barrios V, Jimenez D.

Cardiovasc Ther. 2010 Oct;28(5):295-301. doi: 10.1111/j.1755-5922.2010.00216.x. Epub 2010 Aug 16. Review.

PMID:
20718760
12.

Evaluation and management of atrial fibrillation.

Ali S, Hong M, Antezano ES, Mangat I.

Cardiovasc Hematol Disord Drug Targets. 2006 Dec;6(4):233-44. Review.

PMID:
17378769
13.

Recent advances in oral anticoagulation for atrial fibrillation.

Singh M, Adigopula S, Patel P, Kiran K, Khosla S.

Ther Adv Cardiovasc Dis. 2010 Dec;4(6):395-407. doi: 10.1177/1753944710386844. Epub 2010 Oct 21. Review.

PMID:
20965952
14.

New oral anticoagulants in atrial fibrillation.

Turpie AG.

Eur Heart J. 2008 Jan;29(2):155-65. Epub 2007 Dec 19. Review.

PMID:
18096568
15.

Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.

Salim I, Al Suwaidi J, Ghadban W, Salam AM.

Expert Opin Drug Saf. 2013 Jan;12(1):53-63. doi: 10.1517/14740338.2013.732569. Epub 2012 Oct 24. Review.

PMID:
23095103
16.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Becattini C, Vedovati MC, Agnelli G.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20. Review.

PMID:
22264937
17.
18.

Oral anticoagulants to reduce the risk of stroke in atrial fibrillation: how should a clinician choose?

Mohammed I, Syed W, Kowey PR.

Clin Cardiol. 2013 Nov;36(11):663-70. doi: 10.1002/clc.22173. Epub 2013 Jul 24. Review.

19.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24. Review.

PMID:
22537354
20.

Stroke prevention in atrial fibrillation: do we still need warfarin?

Diener HC, Weber R, Lip GY, Hohnloser SH.

Curr Opin Neurol. 2012 Feb;25(1):27-35. doi: 10.1097/WCO.0b013e32834e604a. Review.

PMID:
22143201

Supplemental Content

Support Center